BiotechTube
Home/Suven Life Sciences/Dr. K. R. Seshagiri
DK

Dr. K. R. Seshagiri

CEO

Suven Life Sciences

Therapeutic Areas

NeurologyNeurodegeneration

Suven Life Sciences Pipeline

DrugIndicationPhase
Masupiridine (SUVN‑502)Alzheimer's disease – cognition and neuropsychiatric symptomsPreclinical

Leadership Team at Suven Life Sciences

DR
Dr. R. K. Reddy
CSO
View full Suven Life Sciences profile